Stock Price Quote

VISTA PHARMACEUTICALS LTD.

NSE : NABSE : 524711ISIN CODE : INE427C01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE10.64-0.07 (-0.65 %)
PREV CLOSE ( ) 10.71
OPEN PRICE ( ) 10.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 645
TODAY'S LOW / HIGH ( )10.31 10.70
52 WK LOW / HIGH ( ) 9.116.59
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 25-01 1991
Management Info
Dhananjaya Alli - Chairman Murali Meraga - Managing Director
Registered Office

Address Plot Nos. 10 To 14 And 16 To 20, T S I I C Industrial Estate,Chityal, Gopalaipalli Village,Narketpally Mandal,
Nalgonda Dist,
Telangana-508254

Phone 08682 272552 / 09291015956

Email admin.hyd@vistapharmaceuticals.com

Website www.vistapharmaceuticals.com

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE

NEWS

25Mar Vista Pharmaceuticals informs about cl
Vista Pharmaceuticals has informed that as per the Company's minimum Sta..
01Mar Vista Pharmaceuticals informs about cl
With reference to covering letter dated 25.02.2025, submitted in terms o..
25Feb Vista Pharmaceuticals submits EGM noti
In terms of Regulations of SEBI (Listing obligations and Disclosure Requ..
03Aug Vista Pharmaceuticals informs about bo
Vista Pharmaceuticals has informed that the meeting of the Board of Dire..
15Jun Vista Pharmaceuticals informs about ou
Vista Pharmaceuticals has informed that at the Board of Directors has ap..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit-14.94-46.49
Gross Profit -10.61 -52.9
Operating Profit -6.7-35.88
Net Sales 32.3100.75

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE)
peergroup  5075.20 (2.17%)
M.Cap ( in Cr)11688.50
Ajanta Pharma (BSE)
peergroup  2585.30 (1.62%)
M.Cap ( in Cr)32293.52
Procter&Gamble Healt (BSE)
peergroup  5891.05 (0.67%)
M.Cap ( in Cr)9778.78
SMS Lifesciences (BSE)
peergroup  1136.65 (2.41%)
M.Cap ( in Cr)343.64
Supriya Lifescience (BSE)
peergroup  681.50 (3.88%)
M.Cap ( in Cr)5484.90

Shareholding Pattern

NON-INSTITUTION 78.79%
PROMOTERS 21.19%
MUTUAL FUNDS/UTI 0.02%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. was incorporated in the year 1991. Its today's share price is 10.64. Its current market capitalisation stands at Rs 61.92 Cr. In the latest quarter, company has reported Gross Sales of Rs. 102.88 Cr and Total Income of Rs.106.21 Cr. The company's management includes Anumala Ravi Chandra kumar, Swapna Priya Gunduboina, Madhu Sudan Anchi, Naga Raja Madineni, Mallem Hanumantha Rao, Barkha Jain, Divakar Reddy Yerrabommanahalli, Umakanth Katta, Stanley Prabhakar Reddy, Rama Mohan Manamasa, Divya Bhavani Chakravarthula, Umesh V Banakar, Pavan Sathvik Gilaka, Murali Meraga, Dhananjaya Alli.

It is listed on the BSE with a BSE Code of 524711 , NSE with an NSE Symbol of and ISIN of INE427C01021. It's Registered office is at Plot Nos. 10 To 14 And 16 To 20, T S I I C Industrial Estate,Chityal, Gopalaipalli Village,Narketpally MandalNalgonda Dist-508254, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AM Reddy & DR Reddy, Mahesh Virender & Sriram, PRV Associates, PVR & Associates, V Kishore Kumar & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.